Samsung Biologics Co.,Ltd.
KSC: 207940.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John Chongbo Rim
- Employees
- 4,770
- Headquarters
- Incheon, South Korea
- IPO year
- 2016
- Market cap
- ₩68.1T
- Website
- https://samsungbiologics.com
Loading 207940…
Loading profile data…Frequently asked questions about 207940
What does Samsung Biologics Co.,Ltd. (207940.KS) do?
Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical me...
Where does 207940.KS trade?
Samsung Biologics Co.,Ltd. (207940.KS) trades on the Korea Exchange.
What sector is 207940.KS in?
Samsung Biologics Co.,Ltd. (207940.KS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Samsung Biologics Co.,Ltd.?
John Chongbo Rim is the chief executive officer of Samsung Biologics Co.,Ltd. (207940.KS).
Where is Samsung Biologics Co.,Ltd. headquartered?
Samsung Biologics Co.,Ltd. is headquartered in South Korea.
Does 207940.KS pay a dividend?
Samsung Biologics Co.,Ltd. (207940.KS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 207940.KS go public?
Samsung Biologics Co.,Ltd. (207940.KS) completed its initial public offering in 2016.